Chao Kong

Previously, Chao Kong worked for SanyouBio Pharmaceuticals for over five years, providing multiple services from antibody discovery to IND enabling studies. He is experienced in pre-clinical target validation, antibody discovery biology, and project management. In addition, he holds a strong background in target biology and cancer immunotherapy.

Chao Kong received a master’s degree from Shanghai University & Shanghai Pasteur Institute of the Chinese Academy of Sciences in China, majoring in Microbiology and Molecular Immunology.